524715 Stock Overview
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Sun Pharmaceutical Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,797.80 |
| 52 Week High | ₹1,960.20 |
| 52 Week Low | ₹1,185.25 |
| Beta | 0.55 |
| 11 Month Change | -2.19% |
| 3 Month Change | 1.22% |
| 1 Year Change | 50.27% |
| 33 Year Change | 134.59% |
| 5 Year Change | 299.69% |
| Change since IPO | 23,097.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524715 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.7% | -0.5% | -1.2% |
| 1Y | 50.3% | 41.6% | 25.5% |
Return vs Industry: 524715 exceeded the Indian Pharmaceuticals industry which returned 41.6% over the past year.
Return vs Market: 524715 exceeded the Indian Market which returned 25.5% over the past year.
Price Volatility
| 524715 volatility | |
|---|---|
| 524715 Average Weekly Movement | 2.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524715 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524715's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 43,000 | Dilip Shanghvi | www.sunpharma.com |
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs.
Sun Pharmaceutical Industries Limited Fundamentals Summary
| 524715 fundamental statistics | |
|---|---|
| Market cap | ₹4.31t |
| Earnings (TTM) | ₹110.54b |
| Revenue (TTM) | ₹503.08b |
39.0x
P/E Ratio8.6x
P/S RatioIs 524715 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524715 income statement (TTM) | |
|---|---|
| Revenue | ₹503.08b |
| Cost of Revenue | ₹112.67b |
| Gross Profit | ₹390.41b |
| Other Expenses | ₹279.87b |
| Earnings | ₹110.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 46.07 |
| Gross Margin | 77.60% |
| Net Profit Margin | 21.97% |
| Debt/Equity Ratio | 3.0% |
How did 524715 perform over the long term?
See historical performance and comparison